The role of public-private partnerships in addressing the biomedical innovation challenge

Nature Reviews Drug Discovery

Volumn 13, Issue 11, 2014, Pages 789-790

  Said, Maya ^a   Zerhouni, Elias ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; BIOMEDICINE; BIOTECHNOLOGY; CANCER RESEARCH; DRUG RESEARCH; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HUMAN GENOME PROJECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE; MEDICAL RESEARCH; NOTE; PATENT; PROGRAM DEVELOPMENT; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; PUBLIC-PRIVATE PARTNERSHIP; STANDARDIZATION; COOPERATION; DRUG DEVELOPMENT; DRUG INDUSTRY; HUMAN; PROCEDURES; PUBLIC HEALTH;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PUBLIC HEALTH; PUBLIC-PRIVATE SECTOR PARTNERSHIPS;

EID: 84908480931     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4438     Document Type: Note

References (5)

1. Accelerating Medicines Partnership: http://www.nih.gov/science/amp/index.htm
2. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products: http://www.fda.gov/downloads/scienceresearch/specialtopics/criticalpathinitiative/criticalpathopportunitiesreports/ucm113411.pdf
3. Innovative Medicines Initiative: http://www.imi.europa.eu/
4. Project Data Sphere: https://www.projectdatasphere.org/projectdatasphere/html/home.html
5. TransCelerate BioPharma: http://www.transceleratebiopharmainc.com